Symbiox Inv & Trading Company Share Price
Sector: Retail (Apparel)
3.19 -0.08 (-2.45%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
3.18
Today’s High
3.33
52 Week Low
2.35
52 Week High
6.02
Key Metrics
- Market Cap (In Cr) 9.98
- Beta 1.69
- Div. Yield (%) 0
- P/B 0.32
- TTM P/E 36.41
- Peg Ratio 0.49
- Sector P/E 0
- Open Price 3.27
- Prev Close 3.27
Symbiox Inv & Trading Company Analysis
Price Analysis
-
1 Week0%
-
3 Months-20.82%
-
6 Month-4.11%
-
YTD-39.67%
-
1 Year21.11%
Risk Meter
- 52% Low risk
- 52% Moderate risk
- 52% Balanced Risk
- 52% High risk
- 52% Extreme risk
Symbiox Inv & Trading Company Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 3.9
- Selling/ General/ Admin Expenses Total
- 0.18
- Other Operating Expenses Total
- 0.23
- Total Operating Expense
- 3.88
- Operating Income
- 0.02
- Net Income Before Taxes
- 0.25
- Net Income
- 0.21
- Diluted Normalized EPS
- 0.07
- Period
- 2024
- Total Assets
- 31.84
- Total Liabilities
- 0.3
- Total Equity
- 31.53
- Tangible Book Valueper Share Common Eq
- 10.08
- Period
- 2024
- Cashfrom Operating Activities
- -3.06
- Cashfrom Investing Activities
- 2.83
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.23
- Period
- 2023
- Total Revenue
- 3.98
- Selling/ General/ Admin Expenses Total
- 0.19
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.36
- Total Operating Expense
- 3.78
- Operating Income
- 0.2
- Net Income Before Taxes
- 0.22
- Net Income
- 0.16
- Diluted Normalized EPS
- 0.05
- Period
- 2023
- Total Assets
- 32.76
- Total Liabilities
- 1.44
- Total Equity
- 31.32
- Tangible Book Valueper Share Common Eq
- 10.01
- Period
- 2023
- Cashfrom Operating Activities
- -4.47
- Cashfrom Investing Activities
- 4.82
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.35
- Period
- 2022
- Total Revenue
- 1.05
- Selling/ General/ Admin Expenses Total
- 0.16
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.4
- Total Operating Expense
- 1.65
- Operating Income
- -0.6
- Net Income Before Taxes
- 0.19
- Net Income
- 0.14
- Diluted Normalized EPS
- 0.04
- Period
- 2022
- Total Assets
- 31.81
- Total Liabilities
- 0.65
- Total Equity
- 31.17
- Tangible Book Valueper Share Common Eq
- 9.96
- Period
- 2022
- Cashfrom Operating Activities
- -0.35
- Cashfrom Investing Activities
- 0.4
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.04
- Period
- 2021
- Total Revenue
- 2.08
- Selling/ General/ Admin Expenses Total
- 0.15
- Other Operating Expenses Total
- 0.31
- Total Operating Expense
- 2.99
- Operating Income
- -0.92
- Net Income Before Taxes
- 0.09
- Net Income
- 0.07
- Diluted Normalized EPS
- 0.02
- Period
- 2021
- Total Assets
- 33.25
- Total Liabilities
- 2.29
- Total Equity
- 30.96
- Tangible Book Valueper Share Common Eq
- 9.9
- Period
- 2021
- Cashfrom Operating Activities
- 1.14
- Cashfrom Investing Activities
- -1
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.14
- Period
- 2020
- Total Revenue
- 1.04
- Selling/ General/ Admin Expenses Total
- 0.13
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.29
- Total Operating Expense
- 1.97
- Operating Income
- -0.93
- Net Income Before Taxes
- 0.03
- Net Income
- 0.02
- Diluted Normalized EPS
- 0.01
- Period
- 2020
- Total Assets
- 31.98
- Total Liabilities
- 1.09
- Total Equity
- 30.89
- Tangible Book Valueper Share Common Eq
- 9.87
- Period
- 2020
- Cashfrom Operating Activities
- 0.27
- Cashfrom Investing Activities
- -0.38
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.11
- Period
- 2019
- Total Revenue
- 0.9
- Selling/ General/ Admin Expenses Total
- 0.15
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.12
- Total Operating Expense
- 1.71
- Operating Income
- -0.82
- Net Income Before Taxes
- 0.04
- Net Income
- -0.01
- Diluted Normalized EPS
- 0
- Period
- 2019
- Total Assets
- 33.81
- Total Liabilities
- 2.94
- Total Equity
- 30.87
- Tangible Book Valueper Share Common Eq
- 9.87
- Period
- 2019
- Cashfrom Operating Activities
- 1.43
- Cashfrom Investing Activities
- -1.55
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.12
- Period
- 2024-12-31
- Total Revenue
- 0.45
- Selling/ General/ Admin Expenses Total
- 0.03
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.02
- Total Operating Expense
- 0.24
- Operating Income
- 0.21
- Net Income Before Taxes
- 0.21
- Net Income
- 0.16
- Diluted Normalized EPS
- 0.05
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 0.75
- Selling/ General/ Admin Expenses Total
- 0.04
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.04
- Total Operating Expense
- 0.31
- Operating Income
- 0.44
- Net Income Before Taxes
- 0.44
- Net Income
- 0.33
- Diluted Normalized EPS
- 0.11
- Period
- 2024-09-30
- Total Assets
- 32.03
- Total Liabilities
- 0.16
- Total Equity
- 31.86
- Tangible Book Valueper Share Common Eq
- 10.18
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 0.93
- Cashfrom Investing Activities
- -1.12
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.19
- Period
- 2024-06-30
- Total Revenue
- 0.31
- Selling/ General/ Admin Expenses Total
- 0.04
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.14
- Total Operating Expense
- 0.3
- Operating Income
- 0.01
- Net Income Before Taxes
- 0.01
- Net Income
- 0.01
- Diluted Normalized EPS
- 0
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 1.12
- Selling/ General/ Admin Expenses Total
- 0.03
- Other Operating Expenses Total
- 0.07
- Total Operating Expense
- 1.22
- Operating Income
- -0.1
- Net Income Before Taxes
- -0.07
- Net Income
- -0.03
- Diluted Normalized EPS
- -0.01
- Period
- 2024-03-31
- Total Assets
- 31.84
- Total Liabilities
- 0.3
- Total Equity
- 31.53
- Tangible Book Valueper Share Common Eq
- 10.08
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -3.06
- Cashfrom Investing Activities
- 2.83
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.23
- Period
- 2023-12-31
- Total Revenue
- 0.18
- Selling/ General/ Admin Expenses Total
- 0.04
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.02
- Total Operating Expense
- 0.25
- Operating Income
- -0.07
- Net Income Before Taxes
- -0.01
- Net Income
- -0.01
- Diluted Normalized EPS
- 0
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Symbiox Inv & Trading Company Technical
Moving Average
SMA
- 5 Day3.27
- 10 Day3.23
- 20 Day3.19
- 50 Day3.39
- 100 Day3.98
- 300 Day3.61
Symbiox Inv & Trading Company Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Zodiac Clothing Co
- 108.85
- -0.94
- -0.86
- 176.95
- 81
- 277.98
- Balgopal Commercial
- 136
- 2
- 1.49
- 172.45
- 33.36
- 258.53
- Heads Up Ventures
- 11.39
- 0.06
- 0.53
- 17.99
- 8.61
- 25.15
- 7nr Retail
- 5.06
- -0.4
- -7.33
- 8.3
- 3.8
- 14.17
- Symbiox Inv & Trading Company
- 3.19
- -0.08
- -2.45
- 6.02
- 2.35
- 9.98
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Zodiac Clothing Co
- -
- 1.16
- -7.23
- -12.88
- Balgopal Commercial
- 18.05
- 7.37
- 16.93
- 26.97
- Heads Up Ventures
- -
- 1.69
- -34.2
- -34.38
- 7nr Retail
- -
- 0.48
- -0.66
- -0.54
- Symbiox Inv & Trading Company
- 48.81
- 0.32
- 0.39
- 4.97
Symbiox Inv & Trading Company Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 11-Feb-25
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 14-Aug-24
- Quarterly Results
- 30-May-24
- Audited Results
- 13-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 09-Oct-23
- Others
- 12-Aug-23
- Quarterly Results
- 29-May-23
- Audited Results
- 17-Apr-23
- Others
- Meeting Date
- Announced on
- Purpose
- 27-Sept-24
- 02-Sept-24
- AGM
- 29-Sept-23
- 20-Sept-23
- AGM
- 20-Mar-23
- 17-Feb-23
- EGM



